Sabra Health Care REIT In...

NASDAQ: SBRA · Real-Time Price · USD
18.41
-0.04 (-0.19%)
At close: Aug 15, 2025, 3:04 PM

Sabra Health Care REIT Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
733.04M 722.42M 711.07M 693.11M 676.74M 659.37M 648.5M 649.1M 628.24M 623.03M 624.81M 595.48M 583.31M 580.28M 569.54M 585.94M 600.6M 601.59M
Cost of Revenue
229.36M 264.69M 301.67M 334.58M 334.92M 287.22M 238.12M 189.16M 182.16M 172.3M 162.61M 156.2M 150.21M 145.24M 141.2M 136.91M 134.07M 133.47M
Gross Profit
503.68M 457.73M 409.41M 358.52M 341.81M 372.15M 410.38M 459.94M 446.08M 450.73M 462.2M 439.28M 433.1M 435.05M 428.34M 449.03M 466.53M 468.12M
Operating Income
271.15M 268.82M 262.07M 264.71M 349.04M 337.1M 326.36M 228.37M 117.19M 118.35M 134.58M 164.49M 165.87M 172.87M 169.69M 233.38M 253.25M 255.03M
Interest Income
n/a n/a n/a 15.6M 15.6M 15.6M 15.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
183.14M 141.51M 127.72M 98.29M 54.12M 51.22M 15.76M -86.72M -121.55M -126.01M -76.36M -15.36M 44.44M -104.67M -111.41M -51.1M -25.09M 137.01M
Net Income
182.33M 140.76M 126.71M 97.17M 52.28M 49.5M 13.76M -88.35M -123.31M -127.69M -77.61M -17.01M 43.28M -106.1M -113.26M -51.79M -25.55M 136.65M
Selling & General & Admin
50.68M 50.91M 50.07M 53.71M 52.07M 48.86M 47.47M 41.65M 40.56M 39.68M 39.57M 36.96M 35.97M 36.13M 34.67M 34.54M 33.07M 32.93M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
85.77M 42.26M 27.61M -16.26M -14.03M -24.07M 43.2M 94.97M 93.73M 148.59M 141.71M 91.61M 90.9M 45.97M 373K 232K 70K 28K
Operating Expenses
136.45M 134.61M 136.53M 83M 124.93M 124.77M 173.24M 232.49M 235.04M 234.49M 227.5M 221.93M 218.74M 218.38M 217.59M 215.65M 213.28M 213.09M
Interest Expense
85.1M 86.86M 115.27M 130.73M 129.42M 128.43M 128.56M 112.92M 111.84M 109.04M 105.47M 103.25M 100.42M 99.16M 98.63M 97.48M 98.14M 99.16M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -20.07M -20.07M -20.07M -20.07M -26.43M -26.43M -26.43M -26.43M -24.65M -24.65M -24.65M
Cost & Expenses
305.88M 297.59M 396.42M 375.81M 418.07M 412M 411.36M 421.65M 417.2M 406.79M 390.11M 378.13M 368.95M 363.62M 358.8M 352.56M 347.35M 346.56M
Income Tax Expense
199K 139K 1M 1.12M 1.84M 1.73M 2M 1.63M 1.76M 1.69M 1.24M 1.65M 1.16M 1.43M 1.84M 687K 457K 368K
Shares Outstanding (Basic)
237.98M 237.89M 236.6M 234.29M 231.62M 231.45M 231.22M 231.22M 231.2M 231.16M 230.99M 230.98M 230.97M 230.86M 219.31M 220.87M 214.42M 211.45M
Shares Outstanding (Diluted)
240.93M 240.3M 239.64M 237.04M 233.75M 233.37M 233.2M 231.22M 232.24M 231.16M 230.99M 230.98M 231.68M 231.56M 227.52M 222.06M 216.26M 212.62M
EPS (Basic)
0.78 0.60 0.54 0.41 0.22 0.21 0.06 -0.38 -0.54 -0.56 -0.34 -0.08 0.19 -0.5 -0.52 -0.23 -0.1 0.66
EPS (Diluted)
0.76 0.59 0.53 0.41 0.22 0.21 0.06 -0.39 -0.54 -0.56 -0.34 -0.08 0.19 -0.49 -0.51 -0.22 -0.09 0.66
EBITDA
475.39M 447.02M 436.12M 423.74M 423.1M 416.11M 418.43M 269.51M 165.22M 167.41M 176.07M 259.11M 506.51M 343.04M 333.96M 401.2M 264.12M 423.16M
EBIT
303.28M 263.42M 250.72M 213.42M 167.94M 164.06M 128.72M 26.21M 54.15M 46.9M 92.97M 151.75M 144.86M -5.51M -12.78M 46.38M 73.05M 236.18M
Depreciation & Amortization
172.11M 170.2M 169.62M 170.19M 170.71M 173.17M 183.09M 190.14M 194.32M 195.35M 187.78M 182.93M 180.55M 179.87M 178.99M 178.07M 177.23M 176.94M